<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03008486</url>
  </required_header>
  <id_info>
    <org_study_id>2016/292</org_study_id>
    <nct_id>NCT03008486</nct_id>
  </id_info>
  <brief_title>Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness</brief_title>
  <official_title>Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Géraldine Martens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effects on upper limb spasticity of soft splints
      worn during three weeks three hours a day by patients with stroke or disorders of
      consciousness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with stroke or disorders of consciousness (DOC) are likely to suffer from major
      muscular troubles such as spasticity. This spasticity may induce pain, loss in range of
      motion and permanent joint deformities. The aim of this study is to investigate the effects
      of soft splinting on the hand spasticity in both patients with stroke and patients with
      disorders of consciousness. The investigators plan to include 100 patients (50 stroke - 50
      with DOC) and each subgroup will be divided in two arms: one wearing real soft splints (6 cm
      diameter) three hours a day for 3 three weeks and the other one wearing 'placebo' splints (1
      cm diameter).

      Skin condition will be followed by the nursing team during the three weeks. Spasticity, pain
      and consciousness assessments will be performed at baseline (week 0), after 1 week of
      treatment (week 1) at the end of the treatment (week 3), 1 week later (week 4), 3 weeks later
      (week 6) and three months later (week 12).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the Modified Ashworth Scale</measure>
    <time_frame>Week 0, 1, 3, 4, 6, 12</time_frame>
    <description>Spasticity assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Modified Tardieu Scale</measure>
    <time_frame>Week 0, 1, 3, 4, 6, 12</time_frame>
    <description>Spasticity assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Nociception Coma Scale-Revised</measure>
    <time_frame>Week 0, 1, 3, 4, 6, 12</time_frame>
    <description>Pain assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Visual Analogue Scale</measure>
    <time_frame>Week 0, 1, 3, 4, 6, 12</time_frame>
    <description>Pain assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Palm-finger distance</measure>
    <time_frame>Week 0, 1, 3, 4, 6, 12</time_frame>
    <description>Range of motion assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the Coma Recovery Scale-Revised</measure>
    <time_frame>Week 0, 1, 3, 4, 6, 12</time_frame>
    <description>Consciousness assessment</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Brain Injuries</condition>
  <condition>Disorder of Consciousness</condition>
  <condition>Stroke</condition>
  <condition>Spasticity as Sequela of Stroke</condition>
  <condition>Contracture</condition>
  <condition>Hypertonic Disorder</condition>
  <condition>Central Nervous System Diseases</condition>
  <condition>Pathologic Processes</condition>
  <condition>Craniocerebral Trauma</condition>
  <condition>Trauma, Nervous System</condition>
  <condition>Neurocognitive Disorders</condition>
  <arm_group>
    <arm_group_label>DOC - real</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spastic patients with disorders of consciousness receiving the real soft splint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DOC - placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Spastic patients with disorders of consciousness receiving the placebo soft splint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stroke - real</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spastic patients stroke receiving the real soft splint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stroke - placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Spastic patients stroke receiving the placebo soft splint</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Real soft splint (6 cm)</intervention_name>
    <arm_group_label>DOC - real</arm_group_label>
    <arm_group_label>Stroke - real</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo soft splint (1 cm)</intervention_name>
    <arm_group_label>DOC - placebo</arm_group_label>
    <arm_group_label>Stroke - placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (DOC):

          -  Altered state of consciousness according to international criteria since more than
             three months

          -  Stable condition

          -  Ashworth score &gt; 1 for at least one upper limb joint

        Exclusion Criteria:

          -  Bone fracture/lesion at the upper limbs

          -  Serious neurological disorder (MMSE &gt; 24) prior to the accident

          -  Botox injection on the upper limbs in the 6 months preceding the inclusion

        Inclusion Criteria (stroke):

          -  Central nervous system injury responsible for the spasticity

          -  Ashworth score &gt; 1 for at least one upper limb joint

        Exclusion Criteria:

          -  Bone fracture/lesion at the upper limbs

          -  Serious neurological disorder (MMSE &gt; 24)

          -  Botox injection on the upper limbs in the 6 months preceding the inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Lejeune</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Neurologique William Lennox</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Géraldine Martens, MSc</last_name>
    <phone>+3243669676</phone>
    <email>geraldine.martens@ulg.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline Symaÿs</last_name>
    <phone>+3243662444</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Neurologique William Lennox</name>
      <address>
        <city>Ottignies</city>
        <state>Brabant Wallon</state>
        <zip>1340</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Lejeune</last_name>
      <phone>+3210430211</phone>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2016</study_first_submitted>
  <study_first_submitted_qc>December 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2017</study_first_posted>
  <last_update_submitted>June 1, 2017</last_update_submitted>
  <last_update_submitted_qc>June 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Liege</investigator_affiliation>
    <investigator_full_name>Géraldine Martens</investigator_full_name>
    <investigator_title>PhD student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Contracture</mesh_term>
    <mesh_term>Central Nervous System Diseases</mesh_term>
    <mesh_term>Neurocognitive Disorders</mesh_term>
    <mesh_term>Consciousness Disorders</mesh_term>
    <mesh_term>Pathologic Processes</mesh_term>
    <mesh_term>Craniocerebral Trauma</mesh_term>
    <mesh_term>Trauma, Nervous System</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

